BioCryst Pharmaceuticals
BCRX
#4710
Rank
C$2.36 B
Marketcap
$11.40
Share price
-1.87%
Change (1 day)
54.63%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$1.39 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are C$1.39 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$1.28 B12.55%
2022-12-31C$1.14 B29.37%
2021-12-31C$0.88 B96.28%
2020-12-31C$0.45 B152.19%
2019-12-31C$0.17 B34.61%
2018-12-31C$0.13 B11.92%
2017-12-31C$0.11 B0.15%
2016-12-31C$0.11 B14.57%
2015-12-31C$0.10 B45.69%
2014-12-31C$71.06 M33.54%
2013-12-31C$53.21 M-7.56%
2012-12-31C$57.56 M-16.03%
2011-12-31C$68.56 M56.08%
2010-12-31C$43.92 M-25.35%
2009-12-31C$58.84 M26.47%
2008-12-31C$46.52 M-40.06%
2007-12-31C$77.62 M40.86%
2006-12-31C$55.1 M15.99%
2005-12-31C$47.51 M1162.01%
2004-12-31C$3.76 M76.06%
2003-12-31C$2.13 M15.52%
2002-12-31C$1.85 M-49.1%
2001-12-31C$3.63 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$1.17 B-15.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.44 B 147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.36 M-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.24 B 133.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$52.33 B 3,664.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$53.98 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$86.43 B 6,118.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$1.40 B 1.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$20.45 M-98.53%๐Ÿ‡บ๐Ÿ‡ธ USA